Want to join the conversation?
$NWL 2Q15 Q&A: Chris, Wells Fargo: What's the outlook for commodities? John, CFO: On commodities, we’ve seen the benefit certainly in resin pricing. Our assumptions are that the current rates hold for the balance of the year and we actually see some inflation in resin going into 2016.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.